» Articles » PMID: 7729650

Intestinal Permeability: an Overview

Overview
Specialty Gastroenterology
Date 1995 May 1
PMID 7729650
Citations 266
Authors
Affiliations
Soon will be listed here.
Abstract

The noninvasive assessment of intestinal permeability in humans has a 20-year history. Because the tests are increasingly used in clinical practice and research and because there is much controversy, we reviewed the literature and outlined the potential and possible shortcomings of these procedures. Data was obtained from personal files and from a systemic search through MEDLINE and EMBASE. The principle of the differential urinary excretion of orally administered test markers is explained with reference to the desired physicochemical properties of the markers and how the principle can be exploited to allow assessment of various other gastrointestinal functions. The use of intestinal permeability tests for diagnostic screen for small bowel disease and assessment of responses to treatment, the pathogenesis of disease, normal intestinal physiology, and the effect of drugs and toxins on the intestine is described and reviewed. The controversy surrounding the anatomic location of the permeation pathways that the markers use is highlighted. Noninvasive tests of intestinal permeability have fulfilled early promises of usefulness in clinical practice and research. There is now a need for integrated research into the basic mechanisms of regulatory control of the intestinal barrier function.

Citing Articles

Integrating the lactulose-mannitol test for intestinal permeability with untargeted metabolomics for drug monitoring through dual liquid chromatography-mass spectrometry.

Hildebrand F, Cukaci C, Schoeny H, Baumgartinger C, Stelzer B, Spedicato M Anal Bioanal Chem. 2025; .

PMID: 40014070 DOI: 10.1007/s00216-025-05790-7.


Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection.

Adams L, Li X, Burchmore R, Goodwin R, Wall D Microbiology (Reading). 2024; 170(10).

PMID: 39392674 PMC: 11469068. DOI: 10.1099/mic.0.001504.


From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Dora D, Szocs E, Soos A, Halasy V, Somodi C, Mihucz A Front Immunol. 2024; 15:1434804.

PMID: 39301033 PMC: 11410641. DOI: 10.3389/fimmu.2024.1434804.


Limited support for a direct connection between prebiotics and intestinal permeability - a systematic review.

Acharya B, Tofthagen M, Maciej-Hulme M, Suissa M, Karlsson N Glycoconj J. 2024; 41(4-5):323-342.

PMID: 39287885 PMC: 11522178. DOI: 10.1007/s10719-024-10165-8.


Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine.

van Trijp M, Rios-Morales M, Logtenberg M, Keshtkar S, Afman L, Witteman B J Agric Food Chem. 2024; 72(38):21152-21165.

PMID: 39282870 PMC: 11440495. DOI: 10.1021/acs.jafc.4c03881.